Peter Stenvinkel

Division of Renal Medicine, Huddinge University Hospital, Sweden

Peter Stenvinkel

Academic positions:
- Associate Professor Karolinska Institute Stockholm Sweden
- Senior lecturer at Karolinska University Hospital at Huddinge Stockholm

All industry positions (in last five years):
None declared

Research interests:
Renal disease, atherosclerosis, inflammation, wasting, genetics

Any other information:
Member of American Society of Nephrology, International Society of Nephrology, International Society of Nutrition and Metabolism, Swedish Society of Nephrology and Swedish Society of Hypertension.

- Member of the Baxter Medical Advisory Board 2002.
- Member of the Editorial Board for J Am Soc Nephrol and NDT.
- Reviews papers on a regular basis for Kidney Int, J Am Soc Nephrol, Nephrol Dial Transpl, Am J Kidney Dis, Perit Dial Int, JAMA, Lancet and JIM.

- Söderbergs Foundation awardee 2003
- Karolina Price awardee 2005

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Nephrology > Dialysis & Renal Transplantation (since 15 November 2005)

All recent recommendations

• 3.2
  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.
  Recommended by Caryl Nowson with Catherine Huggins, Peter Stenvinkel
  
• 3.0
  Role of remission clinics in the longitudinal treatment of CKD.
  Recommended by Peter Stenvinkel
  
• 3.3
  Tight blood glucose control is renoprotective in critically ill patients.
  Recommended by Catherine Bouman, Peter Stenvinkel, Andrew Davenport
  
• 3.2
  Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5.
  Recommended by Neil Turner, Peter Stenvinkel
  
• 8.1
  Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
  Recommended by Peter Stenvinkel, Ihab Wahba, Rajiv Agarwal
  
• 4.8
  Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study.
  Recommended by Peter Stenvinkel, William Mitch
  
• 3.0
  Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease.
  Recommended by Peter Stenvinkel
  
• 3.0
  Relationship between moderate to severe kidney disease and hip fracture in the United States.
  Recommended by Peter Stenvinkel
  
• 3.0
  Meta-analysis of frusemide to prevent or treat acute renal failure.
  Recommended by Peter Stenvinkel
  
• 3.2
  Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.
  Recommended by John Sedor, Peter Stenvinkel
  
• 3.0
  'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure.
  Recommended by Peter Stenvinkel
  
• 3.0
  Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
  Recommended by Peter Stenvinkel
  
• 3.0
  A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD.
  Recommended by Peter Stenvinkel
  
• 3.0
  Antiproteinuric effect of oral paricalcitol in chronic kidney disease
  Recommended by Peter Stenvinkel